RecruitingNCT05854667
Lisdexamfetamine and contingency management for methamphetamine use: a four-group trial
About this title
Read the official source — NCT05854667Medication studyAges 18–55CanadaAddiction
Understand this study
Who could participate?
Listed age limits: 18 years to 55 years.
- Listed locations
- Vancouver and 3 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: December 5, 2023
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 440
- Sponsor
- Centre hospitalier de l'Université de Montréal (CHUM)
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- Canada
- Age range
- From 18 Years to 55 Years
- Official registry ID
- NCT05854667
- Official title
Show the full official title
Addition of High Dose Stimulant and Engagement-focused Contingency Management (CM), Alone and in Combination, to Treatment as Usual (TAU) for the Management of Methamphetamine (MA) Use Disorder (ASCME): a Canadian Multi-centre, RCT
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Vancouver · Fredericton · Toronto
1 more locations
- Montreal
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Centre hospitalier de l'Université de Montréal (CHUM), a university.
Who can participate?
Listed age limits: 18 years to 55 years.
Is this study still recruiting?
The registry lists this study as recruiting.
